-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) PT Lowered to $37 at Canaccord
-
-
-
-
-
-
-
Morgan Stanley Reiterates Overweight Rating on Belimo Holding AG (BEAN:SW) (BLHWF)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)
-
-
-
-
-
-
-
FDA accepts Ultragenyx resubmission for rare disease gene therapy UX111
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) Misses Q4 EPS by 14c, provides guidance
-
-
-
-
-
-
-
Leerink on Ultragenyx Pharma (RARE): 'DTX401 Rolling BLA Submitted, Setting Up Launch for Underappreciated Program'
-
-
-
-
-
-
-
Mereo BipPharma Group (MREO) PT Lowered to $2 at Leerink Partners
-
460,633 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

